CJC-1295 (No DAC) and Ipamorelin is a dual-peptide research formulation designed to investigate endogenous growth hormone signaling through complementary biological pathways. CJC-1295 (No DAC) is a modified growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a selective ghrelin receptor (GHSR-1a) agonist. Together, they are widely studied for their coordinated effects on pulsatile growth hormone secretion in controlled laboratory settings.

Current research focuses on endocrine signaling, growth hormone physiology, tissue regeneration, body composition, recovery mechanisms, and age-related biological processes. Timeless Peptides supplies this formulation exclusively for laboratory and scientific research purposes.

• Investigated for synergistic stimulation of endogenous growth hormone release.

• Studied for pulsatile growth hormone secretion through complementary GHRH and ghrelin receptor pathways.

• Research explores endocrine regulation, recovery mechanisms, and tissue regeneration.

• Evaluated for body composition, metabolic signaling, and healthy aging research models.

• Manufactured in FDA-registered facilities and independently third-party tested for identity and purity.

• Intended exclusively for laboratory research and not for human consumption.

• Store refrigerated between 2°C and 8°C (36°F–46°F).

• Protect from direct light, excessive heat, and moisture.

• Keep the vial sealed until ready for laboratory use.

• After reconstitution, maintain refrigeration and minimize repeated temperature fluctuations.

• Use sterile laboratory handling procedures throughout preparation and storage.

• For research use only. Keep out of reach of unauthorized personnel.